He also has vast expertise in leading collaborative international projects such as the EU H2020 ALIVER and CARBALIVE. Together with Prof. Vicente Arroyo, Director of the EF Clif, they will lead the Strategic Research Program of the Foundation.
Rajiv Jalan (MBBS, MD, PhD, FRCP, FRCPE, FAASLD) is currently Professor of Hepatology at the Institute for Liver and Digestive Health, UCL Medical School and Hon Consultant at the Royal Free Hospital. He has just finished his term as Editor in Chief of Journal of Hepatology and is a Founder member of the EASL Clif Consortium. Prof Jalan will join EF Clif in March 2020 with the ambitious aim of providing leadership to investigate the clinical, pathophysiological and novel therapeutics for patients with cirrhosis in order to significantly diminish the number of deaths within the next 10 years. He aims to achieve this by consolidating the huge influence EF Clif has had in leading, re-defining, performing and disseminating studies in the field. Another major challenge for this new era will be to harmonise definitions and treatment paradigms, which will need to change based on better understanding of the disease state. We wish Prof Jalan a very successful future in achieving his stated vision for EF Clif.